Skip to main content
Clinical Trials/IRCT20230619058530N2
IRCT20230619058530N2
Recruiting
Phase 3

Randomized Clinical Trial, effects of combination treatment with Tizanidine and long-acting Stimulants in ADHD.

Esfahan University of Medical Sciences0 sites40 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Attention-deficit hyperactivity disorders.
Sponsor
Esfahan University of Medical Sciences
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Clinical diagnosis of Attention Deficit Hyperactivity Disorder according to DSM\-5 criteria
  • completing the informed consent form by parent and patient
  • negative history for any chronic medical diseases
  • negative history for drug induced allergy
  • negative history of receiving any Anti hypertensive, Alpha blockers or Beta blockers during recent three months before study
  • Lack of history of any comorbid psychiatric disorder

Exclusion Criteria

  • Any unexpected physical or mental condition that effects on treatment regimen
  • unwillingness of patients or parents to continue study procedure

Outcomes

Primary Outcomes

Not specified

Similar Trials